OR2W3
gene geneOn this page
Also known as OST718
Summary
OR2W3 (olfactory receptor family 2 subfamily W member 3, HGNC:15021) is a protein-coding gene on chromosome 1q44, encoding Olfactory receptor 2W3 (Q7Z3T1). Odorant receptor.
Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome.
Source: NCBI Gene 343171 — RefSeq curated summary.
At a glance
- GWAS associations: 13
- Clinical variants (ClinVar): 261 total
- MANE Select transcript:
NM_001001957
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:15021 |
| Approved symbol | OR2W3 |
| Name | olfactory receptor family 2 subfamily W member 3 |
| Location | 1q44 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | OST718 |
| Ensembl gene | ENSG00000238243 |
| Ensembl biotype | protein_coding |
| OMIM | 616729 |
| Entrez | 343171 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000360358
RefSeq mRNA: 1 — MANE Select: NM_001001957
NM_001001957
CCDS: CCDS31099
Canonical transcript exons
ENST00000360358 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001410647 | 247895587 | 247896531 |
Expression profiles
Bgee: expression breadth ubiquitous, 145 present calls, max score 90.06.
Top tissues by expression
247 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 90.06 | gold quality |
| blood | UBERON:0000178 | 87.07 | gold quality |
| monocyte | CL:0000576 | 83.02 | gold quality |
| leukocyte | CL:0000738 | 81.51 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 75.53 | gold quality |
| bone marrow | UBERON:0002371 | 73.87 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 71.94 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 71.13 | gold quality |
| thyroid gland | UBERON:0002046 | 69.93 | gold quality |
| prefrontal cortex | UBERON:0000451 | 68.18 | gold quality |
| cortical plate | UBERON:0005343 | 67.50 | gold quality |
| tibial nerve | UBERON:0001323 | 65.30 | gold quality |
| bone marrow cell | CL:0002092 | 64.50 | gold quality |
| granulocyte | CL:0000094 | 64.05 | gold quality |
| hypothalamus | UBERON:0001898 | 63.28 | gold quality |
| right frontal lobe | UBERON:0002810 | 62.57 | gold quality |
| ileal mucosa | UBERON:0000331 | 62.34 | silver quality |
| anterior cingulate cortex | UBERON:0009835 | 62.25 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 61.76 | gold quality |
| frontal cortex | UBERON:0001870 | 61.65 | gold quality |
| neocortex | UBERON:0001950 | 61.09 | gold quality |
| stromal cell of endometrium | CL:0002255 | 59.53 | gold quality |
| nucleus accumbens | UBERON:0001882 | 59.51 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 59.35 | gold quality |
| tibialis anterior | UBERON:0001385 | 59.11 | silver quality |
| pancreatic ductal cell | CL:0002079 | 57.60 | silver quality |
| right lung | UBERON:0002167 | 56.78 | gold quality |
| cerebral cortex | UBERON:0000956 | 56.55 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 55.63 | gold quality |
| caudate nucleus | UBERON:0001873 | 54.99 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 3.05 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 7)
- Our results provided a new insight into susceptibility of USF1 variant with male infertility. rs11204546 of OR2W3 and rs11677854 of GTF2A1L might be additional valuable molecular predictive markers (PMID:25374392)
- A novel missense mutation, c. 424 C > T transition (p.R142W) in OR2W3 gene, was identified as a potentially causative mutation for autosomal dominant Retinitis pigmentosa. (PMID:25783483)
- OR2W3 is associated with genetic susceptibility to Japanese male infertility. (PMID:25847845)
- We therefore conclude that this sequence variant, and hence the OR2W3 gene, do not cause RP. Prompted by these findings and based on simple principles of population genetics, we suggest that WES studies should consider DNA variants as the possible cause of dominant RP only if they are present in less than 1:100,000 individuals from the general population. (PMID:26891008)
- This outstanding specificity of extremely narrowly tuned human OR2M3 can explain both odor qualities and odor threshold trend within a homologous series of 3-mercapto-2-methylalkan-1-ols and suggests a modern human-specific, food-related function of OR2M3 in detecting a single onion key food odorant. (PMID:27916748)
- A signal in a nearby olfactory receptor on chromosome 1, olfactory receptor family 2 subfamily L member 13 (OR2L13), tagged by rs151319968, was nominally associated with PTSD in the AI sample. Although no variants were significantly associated after correction for multiple testing in a meta-analysis of the two cohorts, pathway analysis of the top hits showed an enrichment cluster of terms related to sensory transduction. (PMID:28262088)
- The odorant receptor OR2W3 on airway smooth muscle evokes bronchodilation via a cooperative chemosensory tradeoff between TMEM16A and CFTR. (PMID:33097666)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Or2w3b | ENSMUSG00000060030 |
| mus_musculus | Or2w3 | ENSMUSG00000063549 |
| rattus_norvegicus | ENSRNOG00000074302 |
Paralogs (92): OR2B6 (ENSG00000124657), OR13C9 (ENSG00000136839), OR13C4 (ENSG00000148136), OR2M5 (ENSG00000162727), OR10A5 (ENSG00000166363), OR2D2 (ENSG00000166368), OR2B2 (ENSG00000168131), OR2C1 (ENSG00000168158), OR13J1 (ENSG00000168828), OR10G3 (ENSG00000169208), OR10A3 (ENSG00000170683), OR10A4 (ENSG00000170782), OR10A2 (ENSG00000170790), OR13H1 (ENSG00000171054), OR2K2 (ENSG00000171133), OR2M4 (ENSG00000171180), OR10H2 (ENSG00000171942), OR10H5 (ENSG00000172519), OR10AD1 (ENSG00000172640), OR2Y1 (ENSG00000174339), OR10AG1 (ENSG00000174970), OR2T1 (ENSG00000175143), OR10P1 (ENSG00000175398), OR2T35 (ENSG00000177151), OR2M7 (ENSG00000177186), OR2T12 (ENSG00000177201), OR2T33 (ENSG00000177212), OR2AJ1 (ENSG00000177275), OR2T8 (ENSG00000177462), OR2G3 (ENSG00000177476), OR2G2 (ENSG00000177489), OR2B11 (ENSG00000177535), OR2D3 (ENSG00000178358), OR13D1 (ENSG00000179055), OR10A7 (ENSG00000179919), OR2Z1 (ENSG00000181733), OR2V2 (ENSG00000182613), OR10G7 (ENSG00000182634), OR2T29 (ENSG00000182783), OR2T34 (ENSG00000183310)
Protein
Protein identifiers
Olfactory receptor 2W3 — Q7Z3T1 (reviewed: Q7Z3T1)
Alternative names: Olfactory receptor 2W8, Olfactory receptor OR1-49
All UniProt accessions (1): Q7Z3T1
UniProt curated annotations — full annotation on UniProt →
Function. Odorant receptor.
Subcellular location. Cell membrane.
Similarity. Belongs to the G-protein coupled receptor 1 family.
RefSeq proteins (1): NP_001001957* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000276 | GPCR_Rhodpsn | Family |
| IPR000725 | Olfact_rcpt | Family |
| IPR017452 | GPCR_Rhodpsn_7TM | Domain |
Pfam: PF13853
UniProt features (24 total): topological domain 8, transmembrane region 7, sequence variant 7, chain 1, glycosylation site 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q7Z3T1-F1 | 77.34 | 0.32 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Glycosylation sites (1): 5
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-381753 | Olfactory Signaling Pathway |
| R-HSA-9752946 | Expression and translocation of olfactory receptors |
MSigDB gene sets: 32 (showing top):
GOBP_SENSORY_PERCEPTION_OF_CHEMICAL_STIMULUS, KEGG_OLFACTORY_TRANSDUCTION, GOBP_DETECTION_OF_STIMULUS, GOBP_SENSORY_PERCEPTION, chr1q44, GOMF_OLFACTORY_RECEPTOR_ACTIVITY, GOMF_TRANSMEMBRANE_SIGNALING_RECEPTOR_ACTIVITY, GOMF_G_PROTEIN_COUPLED_RECEPTOR_ACTIVITY, GOBP_SENSORY_PERCEPTION_OF_SMELL, GOBP_G_PROTEIN_COUPLED_RECEPTOR_SIGNALING_PATHWAY, GOBP_DETECTION_OF_STIMULUS_INVOLVED_IN_SENSORY_PERCEPTION, STK33_SKM_DN, TERF2_TARGET_GENES, WP_MALE_INFERTILITY, DESCARTES_FETAL_CEREBRUM_MEGAKARYOCYTES
GO Biological Process (4): detection of chemical stimulus involved in sensory perception of smell (GO:0050911), signal transduction (GO:0007165), G protein-coupled receptor signaling pathway (GO:0007186), sensory perception of smell (GO:0007608)
GO Molecular Function (2): G protein-coupled receptor activity (GO:0004930), olfactory receptor activity (GO:0004984)
GO Cellular Component (2): plasma membrane (GO:0005886), membrane (GO:0016020)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Sensory Perception | 1 |
| Olfactory Signaling Pathway | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| transmembrane signaling receptor activity | 2 |
| sensory perception of smell | 1 |
| detection of chemical stimulus involved in sensory perception | 1 |
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| G protein-coupled receptor activity | 1 |
| signal transduction | 1 |
| sensory perception of chemical stimulus | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| detection of chemical stimulus involved in sensory perception of smell | 1 |
| membrane | 1 |
| cell periphery | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
374 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| OR2W3 | TRIM58 | Q8NG06 | 746 |
| OR2W3 | ZNF214 | Q9UL59 | 494 |
| OR2W3 | PALM3 | A6NDB9 | 413 |
| OR2W3 | FSCN2 | O14926 | 400 |
| OR2W3 | TAS2R38 | P59533 | 386 |
| OR2W3 | TSSC4 | Q9Y5U2 | 383 |
| OR2W3 | CNGA4 | Q8IV77 | 356 |
| OR2W3 | ZHX2 | Q9Y6X8 | 339 |
| OR2W3 | GUCA1B | Q9UMX6 | 337 |
| OR2W3 | RTP2 | Q5QGT7 | 329 |
| OR2W3 | CSMD3 | Q7Z407 | 324 |
| OR2W3 | ROM1 | Q03395 | 307 |
| OR2W3 | CHRM4 | P08173 | 306 |
| OR2W3 | ROBO2 | Q9HCK4 | 305 |
| OR2W3 | RTP1 | P59025 | 299 |
IntAct
2 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| OR2W3 | RHBDD1 | psi-mi:“MI:0915”(physical association) | 0.400 |
BioGRID (2): OR2W3 (Affinity Capture-MS), RHBDD1 (Affinity Capture-MS)
ESM2 similar proteins: A0A2R8YED5, A6NM03, O14581, O60412, O76099, O95006, O95047, O95371, P34982, P34984, P47884, P58170, Q15619, Q15622, Q5TZ20, Q60883, Q60887, Q60891, Q6IFH4, Q7Z3T1, Q8N628, Q8NG84, Q8NG95, Q8NG98, Q8NG99, Q8NGA0, Q8NGA1, Q8NGA2, Q8NGQ5, Q8NGR9, Q8NGS1, Q8NGS2, Q8NGS3, Q8NGV0, Q8NGW1, Q8NGX1, Q8NH06, Q8NH80, Q8NHA4, Q95157
Diamond homologs: A0A2R8YED5, O14581, O43749, O76099, O95221, P0C626, P0C7N1, P0C7N5, P0DN81, P23266, P23275, P30955, P47890, P58173, P58181, P59922, Q15617, Q15619, Q15622, Q60878, Q60881, Q60895, Q6IEU7, Q6UXT6, Q7TQQ0, Q7Z3T1, Q8N0Y5, Q8N146, Q8N162, Q8N628, Q8NG98, Q8NGA1, Q8NGC2, Q8NGE5, Q8NGF4, Q8NGF8, Q8NGG0, Q8NGG3, Q8NGG4, Q8NGG8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
261 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 187 |
| Likely benign | 50 |
| Benign | 22 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
177 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 1:247896342:T:TA | acceptor_gain | 0.8000 |
| 1:247896177:C:T | donor_gain | 0.7600 |
| 1:247896194:CGGT:C | donor_loss | 0.7500 |
| 1:247896196:G:GC | donor_loss | 0.7500 |
| 1:247896197:T:G | donor_loss | 0.7500 |
| 1:247896200:G:C | donor_loss | 0.7400 |
| 1:247896341:AT:A | acceptor_gain | 0.7400 |
| 1:247896192:GGCG:G | donor_gain | 0.7300 |
| 1:247896193:GCGG:G | donor_gain | 0.7300 |
| 1:247896198:GG:G | donor_loss | 0.7100 |
| 1:247896342:T:G | acceptor_gain | 0.7000 |
| 1:247896193:GCG:G | donor_gain | 0.6900 |
| 1:247896144:G:GT | donor_gain | 0.6700 |
| 1:247896093:T:TA | acceptor_gain | 0.6600 |
| 1:247896196:G:GG | donor_gain | 0.6200 |
| 1:247896108:G:GA | donor_gain | 0.6000 |
| 1:247896241:A:AG | acceptor_gain | 0.5900 |
| 1:247896242:G:GG | acceptor_gain | 0.5900 |
| 1:247895846:G:GT | donor_gain | 0.5800 |
| 1:247896201:T:G | donor_loss | 0.5800 |
| 1:247895989:A:AG | donor_gain | 0.5700 |
| 1:247896156:C:A | donor_gain | 0.5700 |
| 1:247896242:GCTA:G | acceptor_gain | 0.5700 |
| 1:247895865:C:G | donor_gain | 0.5600 |
| 1:247896343:G:A | acceptor_gain | 0.5600 |
| 1:247896021:GTC:G | donor_gain | 0.5500 |
| 1:247896107:T:TA | donor_gain | 0.5500 |
| 1:247896237:TTACA:T | acceptor_loss | 0.5500 |
| 1:247896238:TACAG:T | acceptor_loss | 0.5500 |
| 1:247896239:ACAG:A | acceptor_loss | 0.5500 |
AlphaMissense
2027 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 1:247895635:T:C | F17L | 0.780 |
| 1:247895637:C:A | F17L | 0.780 |
| 1:247895637:C:G | F17L | 0.780 |
| 1:247896337:T:C | F251L | 0.736 |
| 1:247896339:C:A | F251L | 0.736 |
| 1:247896339:C:G | F251L | 0.736 |
| 1:247895803:T:C | F73L | 0.710 |
| 1:247895805:C:A | F73L | 0.710 |
| 1:247895805:C:G | F73L | 0.710 |
| 1:247895620:T:C | F12L | 0.686 |
| 1:247895622:C:A | F12L | 0.686 |
| 1:247895622:C:G | F12L | 0.686 |
| 1:247895896:T:C | F104L | 0.666 |
| 1:247895898:C:A | F104L | 0.666 |
| 1:247895898:C:G | F104L | 0.666 |
| 1:247895767:T:C | F61L | 0.659 |
| 1:247895769:C:A | F61L | 0.659 |
| 1:247895769:C:G | F61L | 0.659 |
| 1:247895940:G:A | M118I | 0.634 |
| 1:247895940:G:C | M118I | 0.634 |
| 1:247895940:G:T | M118I | 0.634 |
| 1:247896115:T:C | F177L | 0.621 |
| 1:247896117:C:A | F177L | 0.621 |
| 1:247896117:C:G | F177L | 0.621 |
| 1:247896298:T:C | F238L | 0.621 |
| 1:247896300:C:A | F238L | 0.621 |
| 1:247896300:C:G | F238L | 0.621 |
| 1:247895770:T:C | F62L | 0.615 |
| 1:247895772:C:A | F62L | 0.615 |
| 1:247895772:C:G | F62L | 0.615 |
dbSNP variants (sampled 300 via entrez): RS1000142214 (1:247894941 A>G), RS1002994863 (1:247894851 A>G), RS1003993393 (1:247894606 T>G), RS1005054038 (1:247895442 T>C), RS1005440058 (1:247896622 A>C,G,T), RS1005880893 (1:247895395 A>G), RS1012683870 (1:247895931 G>A,C), RS1014360396 (1:247896966 G>T), RS1014659252 (1:247895061 A>T), RS1014966954 (1:247895447 C>T), RS1015306281 (1:247895019 A>G), RS1016228378 (1:247896429 C>T), RS1019112909 (1:247894948 G>A), RS1020033936 (1:247894402 A>G,T), RS1021501099 (1:247895757 C>T)
Disease associations
OMIM: gene MIM:616729 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
13 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004603_204 | Platelet count | 9.000000e-17 |
| GCST004619_100 | Reticulocyte fraction of red cells | 2.000000e-54 |
| GCST004621_46 | Red cell distribution width | 2.000000e-27 |
| GCST004622_144 | Reticulocyte count | 2.000000e-54 |
| GCST004630_20 | Mean corpuscular hemoglobin | 2.000000e-18 |
| GCST006879_25 | Blood metabolite levels | 9.000000e-16 |
| GCST008529_46 | Tea consumption | 4.000000e-07 |
| GCST90002395_516 | Mean platelet volume | 2.000000e-30 |
| GCST90002395_518 | Mean platelet volume | 7.000000e-42 |
| GCST90002404_7 | Red cell distribution width | 3.000000e-22 |
| GCST90002405_104 | Reticulocyte count | 3.000000e-27 |
| GCST90002405_105 | Reticulocyte count | 1.000000e-10 |
| GCST90002406_1 | Reticulocyte fraction of red cells | 2.000000e-17 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0007986 | reticulocyte count |
| EFO:0009188 | Red cell distribution width |
| EFO:0004527 | mean corpuscular hemoglobin |
| EFO:0010091 | tea consumption measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| triphenyl phosphate | affects expression | 1 |
| 1,6-hexamethylene diisocyanate | affects expression | 1 |
| trimellitic anhydride | affects expression | 1 |
| ammonium hexachloroplatinate | affects expression | 1 |
| zinc chromate | decreases expression, increases abundance | 1 |
| potassium chromate(VI) | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects response to substance, increases expression, affects cotreatment, decreases expression | 1 |
| chromium hexavalent ion | decreases expression, increases abundance | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases expression, increases abundance | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Fenfluramine | increases expression | 1 |
| Lipopolysaccharides | increases expression, affects cotreatment, decreases expression, affects response to substance | 1 |
| Malathion | increases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Asbestos, Crocidolite | affects expression | 1 |
| Sodium Selenite | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Particulate Matter | increases abundance, increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.